Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
L'Europe
EU
Nanobiotix (NANO)
Nanobiotix (NANO) Actualités

NANO

Nanobiotix (NANO)

Nanobiotix

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:EU:NANO

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
11/07/2023	00h37	Dow Jones News	ADRs End Mostly Lower, Nanobiotix and Taiwan Semiconductor Manufacturing Trade Actively	EU:NANO	Nanobiotix
10/07/2023	13h37	Dow Jones News	ECHO BOURSE: Nanobiotix bondit de 51% après un accord de licence avec Janssen	EU:NANO	Nanobiotix
10/07/2023	12h57	Dow Jones News	Nanobiotix Shares Soar on Licensing Deal With J&J Unit	EU:NANO	Nanobiotix
05/05/2023	19h11	Dow Jones News	ECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envole	EU:NANO	Nanobiotix
09/07/2019	20h45	GlobeNewswire Inc.	Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet Oncology	EU:NANO	Nanobiotix
01/07/2019	08h00	GlobeNewswire Inc.	Nanobiotix announces new organizational structure as the company enters its next stage after first european market approval	EU:NANO	Nanobiotix
04/06/2019	08h00	GlobeNewswire Inc.	NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVAL	EU:NANO	Nanobiotix
28/05/2019	07h00	GlobeNewswire Inc.	Nanobiotix announces the launch of curadigm : a new nanotechnology platform for healthcare	EU:NANO	Nanobiotix
04/04/2019	18h31	GlobeNewswire Inc.	Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval	EU:NANO	Nanobiotix
02/04/2019	18h56	GlobeNewswire Inc.	Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pr...	EU:NANO	Nanobiotix
26/03/2019	08h00	GlobeNewswire Inc.	Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback	EU:NANO	Nanobiotix
15/03/2019	18h40	GlobeNewswire Inc.	Nanobiotix 2018 Annual Results	EU:NANO	Nanobiotix
15/11/2018	13h00	GlobeNewswire Inc.	Nanobiotix revenues for the 3rd quarter of 2018	EU:NANO	Nanobiotix
19/10/2018	14h05	GlobeNewswire Inc.	NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMO	EU:NANO	Nanobiotix
16/10/2018	04h13	GlobeNewswire Inc.	Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank	EU:NANO	Nanobiotix
26/09/2018	04h00	GlobeNewswire Inc.	Nanobiotix to present positive results from its phase II/III clinical trial of NBTXR3 in patients with Soft Tissue Sarcoma (S...	EU:NANO	Nanobiotix
20/09/2018	04h04	GlobeNewswire Inc.	Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018	EU:NANO	Nanobiotix
04/09/2018	18h20	GlobeNewswire Inc.	NANOBIOTIX half year results for the six months ended June 30, 2018	EU:NANO	Nanobiotix
26/07/2018	18h32	GlobeNewswire Inc.	NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment Bank	EU:NANO	Nanobiotix
22/06/2018	14h29	Dow Jones News	Nanobiotix offre un succès bienvenu pour relancer les biotechs tricolores - DJ Plus	EU:NANO	Nanobiotix
21/06/2018	19h41	GlobeNewswire Inc.	NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3	EU:NANO	Nanobiotix
06/06/2018	15h55	GlobeNewswire Inc.	NANOBIOTIX' Management statement on recent share price variation	EU:NANO	Nanobiotix
14/05/2018	08h57	Cercle Finance	Calendrier des sociétés sur 15 jours	EU:NANO	Nanobiotix
03/05/2018	19h35	GlobeNewswire Inc.	Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathwa...	EU:NANO	Nanobiotix
17/04/2018	20h01	GlobeNewswire Inc.	AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING path...	EU:NANO	Nanobiotix
11/04/2018	09h01	Cercle Finance	Nanobiotix: projet de recherche avec le MD Anderson	EU:NANO	Nanobiotix
10/04/2018	20h42	GlobeNewswire Inc.	NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-...	EU:NANO	Nanobiotix
30/03/2018	16h03	GlobeNewswire Inc.	NANOBIOTIX : Nanobiotix 2017 Annual Results	EU:NANO	Nanobiotix
22/01/2018	15h03	Cercle Finance	Nanobiotix:titre bien orienté après des données prometteuses	EU:NANO	Nanobiotix
22/01/2018	08h02	GlobeNewswire Inc.	NANOBIOTIX presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical On...	EU:NANO	Nanobiotix

Showing the most relevant articles for your search:EU:NANO

1 2 3 4 5 Suivant >>

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales